Source: MarketScreener

Achillion: Achillion Pharmaceuticals : Ahold Delhaize share buyback update August 11, 2020

(marketscreener.com) Zaandam, the Netherlands, August 11, 2020 - Ahold Delhaize has repurchased 380,000 of Ahold Delhaize common shares in the period from August 3, 2020 up to and including August 7, 2020. The shares were repurchased at an average price of €25.78 per share for a total consideration of € 9.8 million. These repurchases were...https://www.marketscreener.com/ACHILLION-PHARMACEUTICALS-35614/news/Achillion-Pharmaceuticals-Ahold-Delhaize-share-buyback-update-August-11-2020-31096516/?utm_medium=RSS&utm_content=20200811

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joseph Truitt's photo - President & CEO of Achillion Pharmaceuticals Inc

President & CEO

Joseph Truitt

CEO Approval Rating

87/100

Read more